Infinite Genomics LLC

Infinite Genomics LLC was paid $1.98M by Medicaid between Jan 2022 and Dec 2024, across 34 billing codes. Its largest line is 87798, Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism — 37% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2022	13,750	$524K
2023	16,371	$791K
2024incomplete	17,597	$664K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	37%	4,568	3,832	$734K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	7.0%	3,683	1,882	$139K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	6.7%	1,798	1,515	$132K
87481		6.6%	2,636	2,305	$131K
87640		4.3%	3,488	3,105	$85K
87631		4.0%	1,074	900	$80K
87653		3.3%	2,804	2,484	$65K
87641		3.2%	3,295	2,893	$64K
87529		3.2%	952	883	$63K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	2.2%	2,214	1,966	$44K
87500		2.2%	2,444	2,190	$44K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	2.2%	1,275	1,179	$43K

22 more codes

87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	2.2%	1,272	$43K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	2.0%	1,542	$39K
87486		1.9%	1,472	$37K
87498		1.9%	1,459	$37K
87541		1.9%	1,458	$37K
87581		1.9%	1,472	$37K
87511		1.4%	858	$27K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	1.3%	320	$25K
87625		1.1%	754	$21K
88312		<1%	569	$12K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	438	$9K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	3,340	$8K
88304		<1%	570	$5K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	12	$5K
88313		<1%	344	$4K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	61	$3K
87471		<1%	421	$3K
88311		<1%	527	$1K
87563		<1%	44	$1K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	45	$445.59
81003		<1%	243	$362.83
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	266	$23.46

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSTAGGS, BRENT (CEO)